Clinical Trials in Special Patient Populations

Overview


The term “special population” exists to protect certain vulnerable patient groups that require additional consideration as it pertains to clinical research, including women, pediatrics, and the elderly.

Regulatory agencies require clinical trial sponsors to present a summary of safety and effectiveness data by demographic subgroups, for age, gender, and ethnicity – because one size does not fit all.

In this webinar, we will explore these different patient populations, outline the challenges to trial recruitment and retention, and overview the regulatory efforts underway to ensure inclusive research.

Speakers

Annemarie Forrest
Annemarie Forrest
Director of Projects
Clinical Trials Transformation Initiative (CTTI)
Christina Brennan, MD, MBA
Christina Brennan, MD, MBA
Vice President of clinical research
The Feinstein Institutes for Medical Research
Jasmine Benger
Jasmine Benger
Senior Project Manager, Research Services
CISCRP
Ben Hargreaves
Ben Hargreaves
Editor
in-PharmaTechnologist and BioPharma-Reporter

View webinar


Thank you, you can now watch the webinar.

Share Event